nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0416	0.0656	CbGpPWpGaD
Secobarbital—Ataxia—Spironolactone—dilated cardiomyopathy	0.0249	0.0683	CcSEcCtD
Secobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.0206	0.0324	CbGpPWpGaD
Secobarbital—Mental disability—Furosemide—dilated cardiomyopathy	0.0172	0.0472	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0153	0.0419	CcSEcCtD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0136	0.0214	CbGpPWpGaD
Secobarbital—Confusional state—Spironolactone—dilated cardiomyopathy	0.0131	0.036	CcSEcCtD
Secobarbital—Somnolence—Spironolactone—dilated cardiomyopathy	0.0116	0.0317	CcSEcCtD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0111	0.0175	CbGpPWpGaD
Secobarbital—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0107	0.0294	CcSEcCtD
Secobarbital—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0103	0.0282	CcSEcCtD
Secobarbital—GRIA2—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.0103	0.0162	CbGpPWpGaD
Secobarbital—Ataxia—Lisinopril—dilated cardiomyopathy	0.0102	0.0279	CcSEcCtD
Secobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0101	0.0159	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0097	0.0153	CbGpPWpGaD
Secobarbital—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0096	0.0263	CcSEcCtD
Secobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00917	0.0144	CbGpPWpGaD
Secobarbital—Dizziness—Spironolactone—dilated cardiomyopathy	0.00862	0.0236	CcSEcCtD
Secobarbital—Vomiting—Spironolactone—dilated cardiomyopathy	0.00829	0.0227	CcSEcCtD
Secobarbital—Rash—Spironolactone—dilated cardiomyopathy	0.00822	0.0225	CcSEcCtD
Secobarbital—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00821	0.0225	CcSEcCtD
Secobarbital—Headache—Spironolactone—dilated cardiomyopathy	0.00817	0.0224	CcSEcCtD
Secobarbital—Agitation—Furosemide—dilated cardiomyopathy	0.00799	0.0219	CcSEcCtD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0079	0.0125	CbGpPWpGaD
Secobarbital—GRIA2—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.00784	0.0123	CbGpPWpGaD
Secobarbital—Nausea—Spironolactone—dilated cardiomyopathy	0.00774	0.0212	CcSEcCtD
Secobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00771	0.0121	CbGpPWpGaD
Secobarbital—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00762	0.0209	CcSEcCtD
Secobarbital—GRIK2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00758	0.0119	CbGpPWpGaD
Secobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00747	0.0118	CbGpPWpGaD
Secobarbital—Hallucination—Lisinopril—dilated cardiomyopathy	0.00745	0.0204	CcSEcCtD
Secobarbital—Confusional state—Furosemide—dilated cardiomyopathy	0.00715	0.0196	CcSEcCtD
Secobarbital—Shock—Furosemide—dilated cardiomyopathy	0.00698	0.0191	CcSEcCtD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00689	0.0109	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00687	0.0108	CbGpPWpGaD
Secobarbital—Hypotension—Furosemide—dilated cardiomyopathy	0.00663	0.0181	CcSEcCtD
Secobarbital—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.00658	0.0104	CbGpPWpGaD
Secobarbital—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00649	0.0102	CbGpPWpGaD
Secobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00641	0.0101	CbGpPWpGaD
Secobarbital—Tension—Lisinopril—dilated cardiomyopathy	0.0064	0.0175	CcSEcCtD
Secobarbital—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.0064	0.0101	CbGpPWpGaD
Secobarbital—Nervousness—Lisinopril—dilated cardiomyopathy	0.00633	0.0173	CcSEcCtD
Secobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00633	0.00997	CbGpPWpGaD
Secobarbital—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00632	0.00995	CbGpPWpGaD
Secobarbital—Somnolence—Furosemide—dilated cardiomyopathy	0.0063	0.0173	CcSEcCtD
Secobarbital—Constipation—Furosemide—dilated cardiomyopathy	0.00606	0.0166	CcSEcCtD
Secobarbital—GRIK2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00605	0.00954	CbGpPWpGaD
Secobarbital—Angioedema—Lisinopril—dilated cardiomyopathy	0.00596	0.0163	CcSEcCtD
Secobarbital—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00594	0.00936	CbGpPWpGaD
Secobarbital—Syncope—Lisinopril—dilated cardiomyopathy	0.00585	0.016	CcSEcCtD
Secobarbital—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00584	0.016	CcSEcCtD
Secobarbital—GRIK2—Neuronal System—ACTN2—dilated cardiomyopathy	0.0058	0.00914	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00579	0.00913	CbGpPWpGaD
Secobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00579	0.00912	CbGpPWpGaD
Secobarbital—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00578	0.0091	CbGpPWpGaD
Secobarbital—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00577	0.00909	CbGpPWpGaD
Secobarbital—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00573	0.0157	CcSEcCtD
Secobarbital—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00567	0.00893	CbGpPWpGaD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00562	0.00886	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00562	0.00885	CbGpPWpGaD
Secobarbital—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00561	0.00884	CbGpPWpGaD
Secobarbital—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00561	0.0153	CcSEcCtD
Secobarbital—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00557	0.00877	CbGpPWpGaD
Secobarbital—Anxiety—Lisinopril—dilated cardiomyopathy	0.00553	0.0151	CcSEcCtD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00552	0.0087	CbGpPWpGaD
Secobarbital—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00551	0.00868	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—ABCC9—dilated cardiomyopathy	0.00551	0.00868	CbGpPWpGaD
Secobarbital—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00543	0.00856	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00543	0.00855	CbGpPWpGaD
Secobarbital—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00542	0.00853	CbGpPWpGaD
Secobarbital—Confusional state—Lisinopril—dilated cardiomyopathy	0.00537	0.0147	CcSEcCtD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00529	0.00834	CbGpPWpGaD
Secobarbital—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00528	0.00833	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—ACTN2—dilated cardiomyopathy	0.00528	0.00832	CbGpPWpGaD
Secobarbital—Shock—Lisinopril—dilated cardiomyopathy	0.00524	0.0143	CcSEcCtD
Secobarbital—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00523	0.0143	CcSEcCtD
Secobarbital—Hypotension—Lisinopril—dilated cardiomyopathy	0.00497	0.0136	CcSEcCtD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00489	0.00771	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00482	0.00759	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00476	0.00749	CbGpPWpGaD
Secobarbital—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00475	0.00748	CbGpPWpGaD
Secobarbital—Somnolence—Lisinopril—dilated cardiomyopathy	0.00473	0.013	CcSEcCtD
Secobarbital—Dizziness—Furosemide—dilated cardiomyopathy	0.00469	0.0128	CcSEcCtD
Secobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00468	0.00738	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00463	0.00729	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00463	0.00729	CbGpPWpGaD
Secobarbital—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00462	0.00728	CbGpPWpGaD
Secobarbital—Constipation—Lisinopril—dilated cardiomyopathy	0.00455	0.0125	CcSEcCtD
Secobarbital—Vomiting—Furosemide—dilated cardiomyopathy	0.00451	0.0123	CcSEcCtD
Secobarbital—CHRNA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00449	0.00707	CbGpPWpGaD
Secobarbital—Rash—Furosemide—dilated cardiomyopathy	0.00447	0.0122	CcSEcCtD
Secobarbital—Dermatitis—Furosemide—dilated cardiomyopathy	0.00447	0.0122	CcSEcCtD
Secobarbital—Headache—Furosemide—dilated cardiomyopathy	0.00444	0.0122	CcSEcCtD
Secobarbital—GRIA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00444	0.00699	CbGpPWpGaD
Secobarbital—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00439	0.012	CcSEcCtD
Secobarbital—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00435	0.00685	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.0043	0.00678	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00423	0.00666	CbGpPWpGaD
Secobarbital—Nausea—Furosemide—dilated cardiomyopathy	0.00421	0.0115	CcSEcCtD
Secobarbital—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00421	0.0115	CcSEcCtD
Secobarbital—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00415	0.00654	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00408	0.00643	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00398	0.00627	CbGpPWpGaD
Secobarbital—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00392	0.0107	CcSEcCtD
Secobarbital—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00385	0.00607	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.0038	0.00599	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00379	0.00596	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00369	0.00582	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00364	0.00574	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00356	0.00561	CbGpPWpGaD
Secobarbital—Dizziness—Lisinopril—dilated cardiomyopathy	0.00352	0.00963	CcSEcCtD
Secobarbital—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00348	0.00548	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00348	0.00548	CbGpPWpGaD
Secobarbital—Vomiting—Lisinopril—dilated cardiomyopathy	0.00338	0.00926	CcSEcCtD
Secobarbital—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00338	0.00532	CbGpPWpGaD
Secobarbital—Rash—Lisinopril—dilated cardiomyopathy	0.00336	0.00919	CcSEcCtD
Secobarbital—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00335	0.00918	CcSEcCtD
Secobarbital—Headache—Lisinopril—dilated cardiomyopathy	0.00333	0.00913	CcSEcCtD
Secobarbital—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00333	0.00525	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00332	0.00523	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00328	0.00517	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00326	0.00514	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00324	0.0051	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00318	0.00501	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00318	0.00501	CbGpPWpGaD
Secobarbital—Nausea—Lisinopril—dilated cardiomyopathy	0.00316	0.00865	CcSEcCtD
Secobarbital—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00313	0.00492	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00309	0.00486	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00305	0.0048	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00286	0.00451	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00278	0.00438	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00268	0.00422	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00266	0.0042	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00259	0.00407	CbGpPWpGaD
Secobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00229	0.00361	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00229	0.00361	CbGpPWpGaD
Secobarbital—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00227	0.00358	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00226	0.00356	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00223	0.00351	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00223	0.00351	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0022	0.00346	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0022	0.00346	CbGpPWpGaD
Secobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00209	0.00329	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00207	0.00326	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00207	0.00326	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00204	0.00322	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00201	0.00317	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00201	0.00317	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00201	0.00316	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00197	0.00311	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00195	0.00308	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00195	0.00308	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00194	0.00305	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00192	0.00302	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00192	0.00302	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00191	0.00301	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00189	0.00298	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00189	0.00297	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00189	0.00297	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00187	0.00295	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00185	0.00291	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00184	0.0029	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00184	0.0029	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00182	0.00286	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00178	0.00281	CbGpPWpGaD
Secobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00175	0.00276	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00175	0.00276	CbGpPWpGaD
Secobarbital—GRIK2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00172	0.00272	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00171	0.0027	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00171	0.00269	CbGpPWpGaD
Secobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.0017	0.00268	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00166	0.00261	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00165	0.0026	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00164	0.00259	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00161	0.00253	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00161	0.00253	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00158	0.00249	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00157	0.00247	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00149	0.00235	CbGpPWpGaD
Secobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00146	0.0023	CbGpPWpGaD
Secobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00144	0.00227	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0014	0.00221	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—RAF1—dilated cardiomyopathy	0.00132	0.00208	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00132	0.00208	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00132	0.00208	CbGpPWpGaD
Secobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00132	0.00207	CbGpPWpGaD
Secobarbital—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.0013	0.00204	CbGpPWpGaD
Secobarbital—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.00128	0.00202	CbGpPWpGaD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00128	0.00202	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00128	0.00201	CbGpPWpGaD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00126	0.00198	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00125	0.00197	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00123	0.00194	CbGpPWpGaD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.0012	0.0019	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—RAF1—dilated cardiomyopathy	0.0012	0.00189	CbGpPWpGaD
Secobarbital—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00117	0.00185	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00114	0.0018	CbGpPWpGaD
Secobarbital—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.00114	0.00179	CbGpPWpGaD
Secobarbital—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00112	0.00176	CbGpPWpGaD
Secobarbital—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.0011	0.00173	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0011	0.00173	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00108	0.00171	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00107	0.00169	CbGpPWpGaD
Secobarbital—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00107	0.00169	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00105	0.00166	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00103	0.00162	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00102	0.0016	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00101	0.00159	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00099	0.00156	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000979	0.00154	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000977	0.00154	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000962	0.00152	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000944	0.00149	CbGpPWpGaD
Secobarbital—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000937	0.00148	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000928	0.00146	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000918	0.00145	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000905	0.00143	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.00084	0.00132	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000829	0.00131	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000791	0.00125	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000758	0.00119	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000737	0.00116	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000724	0.00114	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000711	0.00112	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000704	0.00111	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000704	0.00111	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000694	0.00109	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000671	0.00106	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000671	0.00106	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00063	0.000993	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000625	0.000985	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000606	0.000955	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000588	0.000926	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000532	0.000838	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000509	0.000802	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000479	0.000754	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000452	0.000711	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000446	0.000702	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000435	0.000685	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000433	0.000682	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000409	0.000644	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000408	0.000642	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000396	0.000624	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000389	0.000613	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000382	0.000602	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000373	0.000588	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.00037	0.000583	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000326	0.000514	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000324	0.000511	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000316	0.000498	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000284	0.000448	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000264	0.000416	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000257	0.000405	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000231	0.000365	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000226	0.000355	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00022	0.000346	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000198	0.000312	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	0.000144	0.000228	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	0.000141	0.000222	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	0.000127	0.0002	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	0.000118	0.000185	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	0.000114	0.00018	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	0.000103	0.000162	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	0.0001	0.000158	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	9.78e-05	0.000154	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	8.81e-05	0.000139	CbGpPWpGaD
